Ledger.Open graph →
SEC Form D · filed August 22, 2017

Elucida Oncology, Inc

Offering
$30.0M
Sold
$10.9M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
NEW YORK, NY
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

Ulrich Wiesner · New York, NYDirectorSteven Larson · Minneapolis, MNDirectorSigurdur A. Olafsson · New York, NYDirectorRobert A. Ruffolo · New York, NYDirectorTim A. Boris · New York, NYDirectorIsaac A. Blech · Baltimore, MDDirectorEdward Rosen · New York, NYExec · DirectorMichelle A. Bradbury · New York, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗